Literature DB >> 22154797

Expanding the indications for septal myectomy in patients with hypertrophic cardiomyopathy: results of operation in patients with latent obstruction.

Hartzell V Schaff1, Joseph A Dearani, Steve R Ommen, Paul Sorajja, Rick A Nishimura.   

Abstract

OBJECTIVE: Many patients with symptomatic hypertrophic cardiomyopathy have minimal left ventricular outflow tract gradients, and there is uncertainty whether their limitation is due to diastolic dysfunction or labile outflow tract obstruction. The purpose of this study was to characterize the clinical presentation and outcome of septal myectomy in patients with hypertrophic cardiomyopathy and latent obstruction.
METHODS: Among 749 patients who underwent septal myectomy, 249 had latent obstruction with minimal (0-30 mm Hg) resting gradients preoperatively. All were symptomatic and had more severe left ventricular outflow tract obstruction provoked by Valsalva maneuver or amyl nitrite inhalation during Doppler echocardiography or by stimulation with isoproterenol during catheterization. Clinical characteristics, survival, and functional outcome of these patients were compared with those of 500 patients with more severe resting left ventricular outflow tract obstruction who underwent myectomy during the same period.
RESULTS: Compared with those with severe obstruction, more patients with latent obstruction were male (63% vs 52%, P < .003), but ages were similar (53 ± 14 years vs 52 ± 15 years). Preoperative symptoms and functional limitation were similar in the 2 groups with 86% and 85%, respectively, having New York Heart Association class III or IV disability. Among patients with latent obstruction, mixed venous oxygen saturation was 61.6% ± 19.0% of predicted compared with 56.8% ± 17.3% for those with severe resting obstruction (P < .008). Septal thickness was less in patients with latent obstruction (20 ± 9 mm vs 22 ± 15 mm, P < .001). Early mortality was 1% in each group, and survival at 5 and 10 years was 93% and 87%, respectively, for patients with latent obstruction compared with 93% and 74%, respectively, for patients with severe resting obstruction preoperatively (P = .34). Self-reported late functional status was similar; 3 to 5 years postoperatively, 81% of patients with latent obstruction preoperatively were in New York Heart Association class I or II compared with 77% of patients with severe resting obstruction.
CONCLUSIONS: Patients with obstructive hypertrophic cardiomyopathy who have low resting gradients and latent obstruction may have limiting symptoms comparable to those of patients with more severe resting gradients. Septal myectomy should be offered to these patients because survival and symptom relief are excellent, suggesting that dynamic obstruction is the major hemodynamic problem rather than diastolic dysfunction.
Copyright © 2012 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22154797     DOI: 10.1016/j.jtcvs.2011.10.059

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  14 in total

1.  Safety profile and utility of treadmill exercise in patients with high-gradient hypertrophic cardiomyopathy.

Authors:  Lars Lindholm Sorensen; Hsin-Yueh Liang; Aurelio Pinheiro; Alex Hilser; Veronica Dimaano; Niels Thue Olsen; Thomas Fritz Hansen; Peter Sogaard; Alexandra Nowbar; Chiara Pisanello; Iraklis Pozios; Susan Phillip; Xun Zhou; Roselle Abraham; Theodore P Abraham
Journal:  Am Heart J       Date:  2016-10-20       Impact factor: 4.749

2.  Hypertrophic obstructive cardiomyopathy: the Mayo Clinic experience.

Authors:  Kunal D Kotkar; Sameh M Said; Joseph A Dearani; Hartzell V Schaff
Journal:  Ann Cardiothorac Surg       Date:  2017-07

3.  Results of surgical septal myectomy for obstructive hypertrophic cardiomyopathy: the Tufts experience.

Authors:  Hassan Rastegar; Griffin Boll; Ethan J Rowin; Noreen Dolan; Catherine Carroll; James E Udelson; Wendy Wang; Philip Carpino; Barry J Maron; Martin S Maron; Frederick Y Chen
Journal:  Ann Cardiothorac Surg       Date:  2017-07

Review 4.  Surgical treatment for hypertrophic cardiomyopathy: a historical perspective.

Authors:  Dustin Hang; Anita Nguyen; Hartzell V Schaff
Journal:  Ann Cardiothorac Surg       Date:  2017-07

Review 5.  Hypertrophic Obstructive Cardiomyopathy.

Authors:  Angelika Batzner; Hans-Joachim Schäfers; Konstantin V Borisov; Hubert Seggewiß
Journal:  Dtsch Arztebl Int       Date:  2019-01-25       Impact factor: 5.594

6.  Analysis of 3-dimensional interventricular septum and abnormal muscle bundles models for septal myectomy.

Authors:  Uladzimir Andrushchuk; Artsem Niavyhlas; Vitali Adzintsou; Iryna Haidzel; Hanna Model; Aliaksandr Shket
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-08-15

7.  Medical, surgical and interventional management of hypertrophic cardiomyopathy with obstruction.

Authors:  Sammy Elmariah; Michael A Fifer
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-12

8.  The influence of aortoseptal angulation on provocable left ventricular outflow tract obstruction in hypertrophic cardiomyopathy.

Authors:  Christopher Howell Critoph; Antonios Pantazis; Maria Teresa Tome Esteban; Joel Salazar-Mendiguchía; Efstathios D Pagourelias; James C Moon; Perry Mark Elliott
Journal:  Open Heart       Date:  2014-10-30

Review 9.  Update on hypertrophic cardiomyopathy and a guide to the guidelines.

Authors:  Srijita Sen-Chowdhry; Daniel Jacoby; James C Moon; William J McKenna
Journal:  Nat Rev Cardiol       Date:  2016-09-29       Impact factor: 32.419

10.  Long-term clinical and echocardiographic outcomes of extensive septal myectomy for hypertrophic obstructive cardiomyopathy in Chinese patients.

Authors:  Lei Yao; Li Li; Xiong-Jun Lu; Yan-Ling Miao; Xiao-Ning Kang; Fu-Jian Duan
Journal:  Cardiovasc Ultrasound       Date:  2016-05-17       Impact factor: 2.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.